A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Clinical trial NCT02576665 · TERMINATED

Trial details

NCT number: NCT02576665
Sponsor: Tocagen Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Triple Negative Breast Cancer Pancreatic Cancer Non-Small Cell Lung Cancer Head and Neck Cancer Ovarian Cancer Lymphoma Sarcoma Bladder Cancer Melanoma IDH1 Mutated Solid Tumors IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)

Start date: 2016-07-01
Primary completion: 2019-05-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.